erelzi
Pharmaranks rates Erelzi 3.4/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Erelzi (Etanercept-Szzs) is a medication used to treat Juvenile Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis.
Etanercept-Szzs · by Sandoz
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Etanercept-Szzs
- Form
- Injectable
- Strength
- ETANERCEPT-SZZS 25MG/0.5ML · ETANERCEPT-SZZS 50MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Sandoz
- FDA application
- BLA761042
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Erelzi treat?
- Erelzi (Etanercept-Szzs) may be used to treat juvenile arthritis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Erelzi rated?
- pharmaranks gives Erelzi a composite score of 3.4 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Erelzi?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Erelzi. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Erelzi?
- Erelzi is marketed by Sandoz. You can see Sandoz's full profile, rating, and other products on pharmaranks.
- Is Erelzi a brand-name or generic drug?
- Erelzi is a brand-name product with the active ingredient Etanercept-Szzs.
- Is Erelzi available over the counter?
- No. Erelzi is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Erelzi come in?
- Erelzi is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Erelzi FDA-registered?
- Erelzi is on record with the U.S. FDA under application number BLA761042. You can verify this on its official FDA label.
- Has Erelzi been recalled by the FDA?
- Erelzi has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Erelzi safe?
- There's no single safe-or-not verdict. pharmaranks gives Erelzi a recall-safety score of 68/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ETANERCEPT-SZZS
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming ETANERCEPT-SZZS — the active ingredient in Erelzi, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- adverse event1 reports
- complications of bone marrow transplant1 reports
- hepatosplenic t-cell lymphoma1 reports
- hypotension1 reports
- psoriatic arthropathy1 reports
- tachycardia1 reports
- therapeutic product effect incomplete1 reports
Read these as a signal, not a rate. A report does not mean ETANERCEPT-SZZS caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cuprimine
Penicillamine
advil
Ibuprofen
amjevita
Adalimumab-Atto
chloroquine phosphate
Chloroquine Phosphate
cyltezo
Adalimumab-Adbm
epaned
Enalapril Maleate
Compare Erelzi head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
erelzi
68/100